The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Genentech
Patient- versus clinician-reported symptoms in the POLARIX study.
 
Carrie A. Thompson
No Relationships to Disclose
 
Neha Mehta-Shah
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/UCB Japan; Genentech/Roche; Kyowa Hakko Kirin; Secura Bio
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); C4 Therapeutics (Inst); Celgene (Inst); Corvus Pharmaceuticals (Inst); Daiichi Sankyo; Dizal Pharma (Inst); Genentech/Roche (Inst); Innate Pharma (Inst); Verastem (Inst); Yingli Pharma (Inst)
 
Christopher Flowers
Stock and Other Ownership Interests - Foresight Diagnostics; N Power
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; BeiGene; Bristol-Myers Squibb/Celgene; Celgene; Curio Science; Denovo Biopharma; Epizyme; Foresight Diagnostics; Genentech/Roche; Genmab; Gilead Sciences; Karyopharm Therapeutics; MorphoSys; Pharmacyclics/Janssen; SeaGen; Spectrum Pharmaceuticals
Research Funding - 4D Pharma (Inst); Abbvie (Inst); Acerta Pharma (Inst); Adaptimmune (Inst); Alimera Sciences (Inst); Amgen (Inst); Bayer (Inst); Celgene (Inst); Cellectis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Guardant Health (Inst); Iovance Biotherapeutics (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Millennium (Inst); MorphoSys (Inst); Nektar (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Sanofi (Inst); Takeda (Inst); TG Therapeutics (Inst); Xencor (Inst); ZIOPHARM Oncology (Inst)
 
Gilles A. Salles
Stock and Other Ownership Interests - Owkin
Honoraria - Abbvie; Bayer; Incyte; Regeneron
Consulting or Advisory Role - Abbvie; BeiGene; BMS; Debiopharm Group; Epizyme; Genmab; incyte; Incyte; Ipsen; Janssen; Kite/Gilead; Loxo/Lilly; Miltenyi Biotec; Molecular Partners; morphosys; Nordic Nanovector; Novartis; RAPT Therapeutics; Roche/Genentech; Takeda; Velosbio
 
Herve Tilly
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - ADC Therapeutics; Celgene/Bristol-Myers Squibb; Incyte; Roche
Research Funding - Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Neil Sun Chua
Honoraria - Abbvie
Consulting or Advisory Role - Amgen; Bayer; Incyte; Merck; Roche Canada; Seagen
Research Funding - Roche/Genentech (Inst)
 
René-Olivier Casasnovas
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; Gilead Sciences; Janssen; Merck; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; ADC Therapeutics; Bristol-Myers Squibb; Celgene; Gilead Sciences; Incyte; Janssen; Merck; Roche/Genentech; Takeda
Research Funding - Gilead Sciences (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Gilead Sciences; Janssen; Roche/Genentech; Takeda
 
Fiona Miall
Honoraria - Takeda
Consulting or Advisory Role - Roche; Takeda
Speakers' Bureau - Roche; Takeda
 
Tae Min Kim
Consulting or Advisory Role - AstraZeneca/MedImmune; Janssen Oncology; Novartis; Regeneron; Samsung Bioepis; Takeda; Yuhan
Speakers' Bureau - IMBdx; Janssen Research & Development; Takeda
Research Funding - AstraZeneca
(OPTIONAL) Uncompensated Relationships - AstraZeneca/MedImmune; Boryung; Novartis; Roche/Genentech
 
Cheng-Hong Tsai
Stock and Other Ownership Interests - Abbvie; Amgen; BeiGene
Honoraria - Astellas Pharma; BeiGene; Bristol-Myers Squibb; Chugai Pharma; Harvester Trading Co.; Janssen; Kirin Pharmaceuticals; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Novartis; Pfizer; Roche
Speakers' Bureau - Astellas Amgen BioPharama; Astellas Pharma; Bristol-Myers Squibb; Bristol-Myers Squibb; Harvester Trading Co.; Janssen; Kirin Pharmaceuticals; Novartis; Pfizer
Research Funding - Astellas Amgen BioPharama; Bristol-Myers Squibb
 
Sunita Dwivedy Nasta
Honoraria - Acrotech Biopharma; Acrotech Biopharma
Consulting or Advisory Role - Incyte; Merck; MorphoSys
Research Funding - Aileron Therapeutics; Atara Biotherapeutics; Debiopharm Group; Forty Seven; Incyte; Millennium; Pharmacyclics/Janssen; Rafael Pharmaceuticals; Roche/Genentech
 
Seung Tae Lee
Employment - University of Maryland School of Medicine
 
Veronica Craine
Employment - Roche
 
Avrita Campinha-Bacote
No Relationships to Disclose
 
Jamie H. Hirata
Employment - Genentech/Roche
Stock and Other Ownership Interests - Roche
 
Calvin Lee
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Matthew Dean Sei Sugidono
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
Jonathan W. Friedberg
Research Funding - Enterome (Inst)
Patents, Royalties, Other Intellectual Property - Patient on bone marrow microenvironment signals (I)